142 related articles for article (PubMed ID: 7373050)
21. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
22. [Ecchymotic angioedema revealing childhood systemic lupus erythematosus with anti-C1q antibodies].
Frot AS; Barbarot S; Poignant S; Guyot C; Stalder JF
Ann Dermatol Venereol; 2008; 135(8-9):584-6. PubMed ID: 18789294
[TBL] [Abstract][Full Text] [Related]
23. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease.
Magro CM; Dyrsen ME
J Am Acad Dermatol; 2008 Nov; 59(5):822-33. PubMed ID: 19119098
[TBL] [Abstract][Full Text] [Related]
24. Activation of factor B of the alternative pathway of complement. Assessment by rocket immunoelectrophoresis.
Kajdacsy-Balla A; Doi EM; Bagasra O
Am J Clin Pathol; 1987 Jul; 88(1):66-73. PubMed ID: 3649166
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus.
Yang DH; Chang DM; Lai JH; Lin FH; Chen CH
Rheumatology (Oxford); 2009 Sep; 48(9):1083-7. PubMed ID: 19553377
[TBL] [Abstract][Full Text] [Related]
26. Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.
Taillon-Miller PA; Shreffler DC
J Immunol; 1988 Oct; 141(7):2382-7. PubMed ID: 2459207
[TBL] [Abstract][Full Text] [Related]
27. [Preparation of C4 antiserum and detection of complement C4 activation in plasma with crossed immunoelectrophoresis].
Hou JC; Kou MX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Dec; 7(6):473-4. PubMed ID: 2940011
[No Abstract] [Full Text] [Related]
28. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
[TBL] [Abstract][Full Text] [Related]
29. Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema.
Khan S; Tarzi MD; Doré PC; Sewell WA; Longhurst HJ
Clin Immunol; 2007 Apr; 123(1):14-7. PubMed ID: 17098477
[TBL] [Abstract][Full Text] [Related]
30. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
[TBL] [Abstract][Full Text] [Related]
31. Classical complement activation induced by pregnancy: implications for management of connective tissue diseases.
Hopkinson ND; Powell RJ
J Clin Pathol; 1992 Jan; 45(1):66-7. PubMed ID: 1740520
[TBL] [Abstract][Full Text] [Related]
32. Platelet C4d is highly specific for systemic lupus erythematosus.
Navratil JS; Manzi S; Kao AH; Krishnaswami S; Liu CC; Ruffing MJ; Shaw PS; Nilson AC; Dryden ER; Johnson JJ; Ahearn JM
Arthritis Rheum; 2006 Feb; 54(2):670-4. PubMed ID: 16447243
[TBL] [Abstract][Full Text] [Related]
33. [Investigation of the complement system in clinical practice].
Frémeaux-Bacchi V; Dragon-Durey MA; Blouin J; Mouthon L; Fridman WH
Ann Med Interne (Paris); 2003 Dec; 154(8):529-40. PubMed ID: 15037829
[TBL] [Abstract][Full Text] [Related]
34. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE
Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
[TBL] [Abstract][Full Text] [Related]
35. [Complement: physiopathology, pharmacology and clinical aspects].
Orrico A; Auteri A
Ann Sclavo Collana Monogr; 1985; 2(1-2):3-146. PubMed ID: 3880494
[No Abstract] [Full Text] [Related]
36. Complement activation during CAPD.
Young GA; Kendall S; Brownjohn AM
Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
[TBL] [Abstract][Full Text] [Related]
37. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of the disease-associated complement C4 gene from the HLA-A1, B8, DR3 haplotype.
Ulgiati D; Abraham LJ
Exp Clin Immunogenet; 1996; 13(1):43-54. PubMed ID: 8854088
[TBL] [Abstract][Full Text] [Related]
39. Complement profiles in acute post-streptococcal glomerulonephritis.
Wyatt RJ; Forristal J; West CD; Sugimoto S; Curd JG
Pediatr Nephrol; 1988 Apr; 2(2):219-23. PubMed ID: 3153014
[TBL] [Abstract][Full Text] [Related]
40. Utilization of complement testing in clinical medicine.
Abdul-Aziz K; Faizal AA
Saudi Med J; 2006 Nov; 27(11):1775-7. PubMed ID: 17106567
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
